The trend analysis and comparison of pulmonary arterial hypertension disease burden in China and India from 1990 to 2021: a study based on the Global Burden of Disease 2021 database
Both China and India have large populations, and the disease burden of PAH remains severe. China should focus on strengthening screening interventions for PAH in the middle-aged and elderly populations, while India should particularly focus on strengthening screening and diagnosis for PAH in children under 5 years old to reduce mortality.
Authors
- X. J. Chen
- Lu Yu (ORCID: https://orcid.org/0000-0003-4098-1205)
- Jian‐Guo Dai (ORCID: https://orcid.org/0000-0001-9904-7914)
- Chang Liu (ORCID: https://orcid.org/0000-0002-6479-1839)
- Zhijing Li
- Dongdong Yan
Institutions
- Wuhan Donghu University (CN)
- Wuchang University of Technology (CN)
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1186/s40001-025-03489-0
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00